Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Pantai Hospital Kuala Lumpur Powers Malaysia’s Biggest Marathon with Heart
Every effort counts with a record-breaking 42,000 participants registering for the 17th edition of Malaysia’s premier distance running event.
Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care
Step inside a new era of connected, technology-enabled care designed around patients’ needs.
IHH Healthcare Shines at The Economic Times Healthcare Awards 2025
Explore the award-winning care and innovation across our network.
Gleneagles Hospital Chennai Propels the Frontier of Advanced Cancer Care and Robotic Oncology
On 27 September, over 300 delegates converge to exchange knowledge and deliberate on advanced cancer surgery, robotic oncology, head and neck oncology, radiation therapy, and supportive care.
Gleneagles JPMC Partners Ministry of Health Brunei in Nation-wide Fight Against Non-communicable Diseases
Gleneagles JPMC is reinforcing its commitment to world-class cardiac care as part of Brunei’s whole-of-nation effort to combat non-communicable diseases.
